Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients
Reumatol Clin (Engl Ed)
.
2022 Dec;18(10):625-626.
doi: 10.1016/j.reumae.2022.06.005.
Authors
Jose Luis Morell-Hita
1
,
Juan A Rigual-Bobillo
2
,
Cristina C Macía-Villa
3
Affiliations
1
Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
2
Servicio de Neumología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
3
Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: ccmacia@gmail.com.
PMID:
36435559
PMCID:
PMC9683472
DOI:
10.1016/j.reumae.2022.06.005
No abstract available
Publication types
Letter
MeSH terms
Arthritis, Rheumatoid* / complications
Arthritis, Rheumatoid* / drug therapy
COVID-19* / complications
Humans
Lung Diseases, Interstitial* / complications